WBA Walgreens Boots Alliance
- 10.300
- +0.270+2.69%
- 10.320
- +0.020+0.19%
Walgreens Boots Alliance News
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms
Express News | Walgreens: Available Appointments for Updated 2024-2025 Covid-19 Vaccines Starting Nationwide in US on Sept 6
Express News | Walgreens - Ready to Offer Updated 2024-2025 Covid-19 Vaccines at Stores Nationwide in US
Express News | Walgreens Ready to Offer Updated Covid-19 Vaccine Appointments
Walgreens Boots Alliance Options Spot-On: On August 22nd, 66,364 Contracts Were Traded, With 801.22K Open Interest
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
Walgreens Now Offering Updated COVID-19 Vaccine Appointments
Most Shorted S&P 500 Stocks in July
Analyzing Walgreens Boots Alliance, Inc. (WBA): Among the Best Dividend Stocks Under $50
Check Out What Whales Are Doing With WBA
Walgreens (NASDAQ: WBA) Dividend Cuts Are Coming
Walgreens Boots Alliance To Go Ex-Dividend On August 21st, 2024 With 0.25 USD Dividend Per Share
Walgreens Collaborating With US Drug Research Authority to Boost Clinical Trials
Express News | Walgreens Boots Alliance Inc - Partners With Barda on Phase IV Covid-19 Trial
Express News | Walgreens and Barda Form Strategic Partnership to Strengthen Decentralized Clinical Trials Model and Reporting
Strong Week for Walgreens Boots Alliance (NASDAQ:WBA) Shareholders Doesn't Alleviate Pain of Five-year Loss
Pharmacy Chains Like CVS Health, Walgreens Boots Alliance Confront Shifting Consumer Habits And Profit Pressures
Walgreens and BARDA Form Strategic Partnership to Strengthen Decentralized Clinical Trials Model and Reporting
Is Cash Flow a Problem for Walgreens Boots Alliance?
Walgreens Boots Alliance (WBA) Surpasses Market Returns: Some Facts Worth Knowing
Analysis
Price Target
No Data
